rufinamide
rufinamide is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including Rufinamide, rufinamide, Banzel. Available dosage forms: tablet, film coated, powder, suspension.
Drug details
- Generic Name
- rufinamide
- Brand Names
- Rufinamide, rufinamide, Banzel, RUFINAMIDE
- Application Number
- ANDA217230
- Sponsor
- Aurobindo Pharma Limited
- NDC Codes
- 11
- Dosage Forms
- TABLET, FILM COATED, POWDER, SUSPENSION
- Routes
- ORAL
- Active Ingredients
- RUFINAMIDE
Indications and Usage
1 INDICATIONS AND USAGE Rufinamide is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults. Rufinamide is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults (1)